ICI-based combinations for advanced/metastatic renal cell carcinoma: Highlights from ASCO GU 2023
touchCONGRESS for touchONCOLOGY
Listen to renowned renal cell carcinoma (RCC) expert Prof. Brian Rini review key data presented at the ASCO GU 2023 congress on advances in immune checkpoint inhibitor (ICI)-based regimens for RCC. He also discusses with two additional leading RCC experts, Prof. Elizabeth Plimack and Prof. Thomas Powles, how these data may apply in clinical practice.
Overview:
Clinical themes:
The internationally renowned RCC expert faculty:
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co. Inc. and Exelixis Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023/
Create your
podcast in
minutes
It is Free